122 related articles for article (PubMed ID: 23371794)
1. Description of a bivalent cannabinoid ligand with hypophagic properties.
Fernández-Fernández C; Decara J; Bermúdez-Silva FJ; Sánchez E; Morales P; Gómez-Cañas M; Gómez-Ruíz M; Callado LF; Goya P; Rodríguez de Fonseca F; Martín MI; Fernández-Ruíz J; Meana JJ; Jagerovic N
Arch Pharm (Weinheim); 2013 Mar; 346(3):171-9. PubMed ID: 23371794
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis of Species-Dependent Differential Affinity of 6-Alkoxy-5-Aryl-3-Pyridinecarboxamide Cannabinoid-1 Receptor Antagonists.
Iyer MR; Cinar R; Liu J; Godlewski G; Szanda G; Puhl H; Ikeda SR; Deschamps J; Lee YS; Steinbach PJ; Kunos G
Mol Pharmacol; 2015 Aug; 88(2):238-44. PubMed ID: 26013543
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of novel 4-alkyl-5-thien-2'-yl pyrazole carboxamides.
Lazzari P; Pau A; Tambaro S; Asproni B; Ruiu S; Pinna G; Mastinu A; Curzu MM; Reali R; Bottazzi ME; Pinna GA; Murineddu G
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):254-76. PubMed ID: 22931442
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of novel diarylpyrazole imide analogues as CB1 cannabinoid receptor ligands.
Song KS; Kim MJ; Seo HJ; Lee SH; Jung ME; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2009 Apr; 17(8):3080-92. PubMed ID: 19328001
[TBL] [Abstract][Full Text] [Related]
6. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.
Thomas BF; Francisco ME; Seltzman HH; Thomas JB; Fix SE; Schulz AK; Gilliam AF; Pertwee RG; Stevenson LA
Bioorg Med Chem; 2005 Sep; 13(18):5463-74. PubMed ID: 15994087
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold.
Tu G; Xiong F; Huang H; Kuang B; Li S
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):222-30. PubMed ID: 20565336
[TBL] [Abstract][Full Text] [Related]
9. Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators.
Stefanucci A; Macedonio G; Dvorácskó S; Tömböly C; Mollica A
Amino Acids; 2018 Nov; 50(11):1595-1605. PubMed ID: 30145711
[TBL] [Abstract][Full Text] [Related]
10. Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier.
Receveur JM; Murray A; Linget JM; Nørregaard PK; Cooper M; Bjurling E; Nielsen PA; Högberg T
Bioorg Med Chem Lett; 2010 Jan; 20(2):453-7. PubMed ID: 20015647
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.
Katoch-Rouse R; Pavlova OA; Caulder T; Hoffman AF; Mukhin AG; Horti AG
J Med Chem; 2003 Feb; 46(4):642-5. PubMed ID: 12570386
[TBL] [Abstract][Full Text] [Related]
12. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
Lange JH; van Stuivenberg HH; Coolen HK; Adolfs TJ; McCreary AC; Keizer HG; Wals HC; Veerman W; Borst AJ; de Looff W; Verveer PC; Kruse CG
J Med Chem; 2005 Mar; 48(6):1823-38. PubMed ID: 15771428
[TBL] [Abstract][Full Text] [Related]
13. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor type 1 with variation of spacer length and structure.
Huang G; Pemp D; Stadtmüller P; Nimczick M; Heilmann J; Decker M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4209-14. PubMed ID: 25096297
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity.
Fulp A; Bortoff K; Seltzman H; Zhang Y; Mathews J; Snyder R; Fennell T; Maitra R
J Med Chem; 2012 Mar; 55(6):2820-34. PubMed ID: 22372835
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor-ligand.
Seo HJ; Kim MJ; Lee SH; Lee SH; Jung ME; Kim MS; Ahn K; Kim J; Lee J
Bioorg Med Chem; 2010 Feb; 18(3):1149-62. PubMed ID: 20045337
[TBL] [Abstract][Full Text] [Related]
17. The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats.
Rutkowska M
Acta Pol Pharm; 2004; 61(5):401-3. PubMed ID: 15747698
[TBL] [Abstract][Full Text] [Related]
18. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.
Zhang Y; Gilliam A; Maitra R; Damaj MI; Tajuba JM; Seltzman HH; Thomas BF
J Med Chem; 2010 Oct; 53(19):7048-60. PubMed ID: 20845959
[TBL] [Abstract][Full Text] [Related]
20. Novel antiobesity agents: synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21.
Alvarado M; Decara J; Luque MJ; Hernandez-Folgado L; Gómez-Cañas M; Gómez-Ruiz M; Fernández-Ruiz J; Elguero J; Jagerovic N; Serrano A; Goya P; de Fonseca FR
Bioorg Med Chem; 2013 Apr; 21(7):1708-16. PubMed ID: 23434135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]